Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Breakthrough In Treatment For Kidney Dialysis Patients

13.08.2004


A ground-breaking medical approach which could substantially improve the quality of life for over a million kidney dialysis patients, and bring huge savings to health services around the globe, is one step closer to becoming a reality, thanks to NESTA (the National Endowment of Science, Technology and the Arts) – the organisation that backs UK innovation.

NESTA has invested £95,000 in a university spin-out, Veryan Medical Limited, based at London’s Imperial College, to further develop their ground-breaking approach. The company has been financed to date by NPI Ventures Limited and Imperial College Innovations.

Veryan are dedicated to developing a number of novel medical devices to address urgent, unmet medical needs in the field of vascular disease, the greatest cause of death in the modern world. Their inventions are designed to recreate the natural swirling fluid flow of the body and prevent the development of disease. The first device to be tested in clinical human trials will be the SwirlGraft™ vascular access graft.



Currently, there are over one million people requiring regular connection to a kidney dialysis machine in order to sustain their lives. A majority of these patients have a synthetic vessel, called a vascular access graft, inserted beneath the skin to facilitate regular hypodermic puncturing and to maximize blood-flow to the dialysis machine. However, these grafts typically develop a potentially lethal disease, called ‘intimal hyperplasia’, which can block the downstream junction with the natural vessel in just a few months. This results in most grafts requiring replacement within a year, and many patients require remedial surgery up to three times a year.

SwirlGraft™ has the potential to be the most effective solution to this problem. By ensuring appropriate swirling blood flow through the dialysis graft and into the downstream vein, it stands to greatly reduce the disease by eliminating the stagnant flow regions where intimal hyperplasia proliferates.

The SwirlGraft™ device has been developed by Professor Colin Caro at Imperial College, and comes on the back of research dating back to 1966. Professor Caro is considered to be a world expert on the links between the physics of blood flow and disease. Veryan Medical is headed up by Philip Birch who brings substantial expertise of building and funding early stage healthcare companies.

NESTA’s investment will be used to develop the SwirlGraft™ device from the current experimental proof of concept through to clinical proof of concept. The trials will be based in the Netherlands and will involve 25 dialysis patients fitted with SwirlGraft™ for their vascular access, monitored for a year.

Mark White, NESTA’s Invention and Innovation Director, said: “We are delighted to be investing in a product which meets an urgent need for improved clinical performance, as well as bringing huge benefits to dialysis patients from around the world.”

| alfa
Further information:
http://www.nesta.org.uk

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Thanks for the memory: NIST takes a deep look at memristors

22.01.2018 | Materials Sciences

Radioactivity from oil and gas wastewater persists in Pennsylvania stream sediments

22.01.2018 | Earth Sciences

Saarland University bioinformaticians compute gene sequences inherited from each parent

22.01.2018 | Life Sciences

VideoLinks Wissenschaft & Forschung
Overview of more VideoLinks >>>